These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37235203)

  • 1. Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers.
    Nakai M; Yokoyama D; Sato T; Sato R; Kojima C; Shimosawa T
    Heliyon; 2023 Jun; 9(6):e16547. PubMed ID: 37235203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
    Matsuura T; Fukushima W; Nakagama Y; Kido Y; Kase T; Kondo K; Kaku N; Matsumoto K; Suita A; Komiya E; Mukai E; Nitahara Y; Konishi A; Kasamatsu A; Nakagami-Yamaguchi E; Ohfuji S; Kaneko Y; Kaneko A; Kakeya H; Hirota Y
    Vaccine; 2022 Sep; 40(38):5631-5640. PubMed ID: 36028457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
    Hayer J; Urlaub E
    Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term transition of antibody titers in healthcare workers following the first to fourth doses of mRNA COVID-19 vaccine: Comparison of two automated SARS-CoV-2 immunoassays.
    Taniguchi Y; Suemori K; Tanaka K; Okamoto A; Murakami A; Miyamoto H; Takasuka Y; Yamashita M; Takenaka K
    J Infect Chemother; 2023 May; 29(5):534-538. PubMed ID: 36696921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology.
    Perkmann T; Mucher P; Ösze D; Müller A; Perkmann-Nagele N; Koller T; Radakovics A; Flieder I; Repl M; Marculescu R; Wolzt M; Wagner OF; Binder CJ; Haslacher H
    J Clin Virol; 2023 Jan; 158():105345. PubMed ID: 36462465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays.
    Lau CS; Wong MS; Hoo SP; Heng PY; Phua SK; Aw TC
    Pract Lab Med; 2021 Nov; 27():e00257. PubMed ID: 34660869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence.
    Miller CN; Althoff KN; Schlueter DJ; Anton-Culver H; Chen Q; Garbett S; Ratsimbazafy F; Thomsen I; Karlson EW; Cicek M; Pinto LA; Malin BA; Ohno-Machado L; Williams C; Goldstein D; Kouame A; Ramirez A; Gebo KA; Schully SD;
    mSphere; 2022 Oct; 7(5):e0025722. PubMed ID: 36173112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of time on the sensitivity of SARS-CoV-2 serological testing.
    Torres Ortiz A; Fenn Torrente F; Twigg A; Hatcher J; Saso A; Lam T; Johnson M; Wagstaffe H; Dhillon R; Mai AL; Goldblatt D; Still R; Buckland M; Gilmour K; Grandjean L
    Sci Rep; 2022 Jun; 12(1):10517. PubMed ID: 35732870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers.
    Kim YK; Minn D; Chang SH; Suh JS
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
    Kanji JN; Bailey A; Fenton J; Ling SH; Rivera R; Plitt S; Sligl WI; Taylor S; Turnbull L; Tipples G; Charlton CL
    Vaccine; 2021 Sep; 39(39):5563-5570. PubMed ID: 34454782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response.
    Di Meo A; Miller JJ; Fabros A; Brinc D; Hall V; Pinzon N; Ierullo M; Ku T; Ferreira VH; Kumar D; Pasic MD; Kulasingam V
    J Appl Lab Med; 2022 Jan; 7(1):57-65. PubMed ID: 34342347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study.
    Perkmann T; Mucher P; Perkmann-Nagele N; Radakovics A; Repl M; Koller T; Schmetterer KG; Bigenzahn JW; Leitner F; Jordakieva G; Wagner OF; Binder CJ; Haslacher H
    Microbiol Spectr; 2022 Feb; 10(1):e0140221. PubMed ID: 35196824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G.
    Hibino M; Watanabe S; Kamada R; Tobe S; Maeda K; Horiuchi S; Kondo T
    Intern Med; 2022 Mar; 61(6):811-819. PubMed ID: 34980798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).
    Isgrò MA; Trillò G; Russo L; Tornesello AL; Buonaguro L; Tornesello ML; Miscio L; Normanno N; Bianchi AAM; Buonaguro FM; Cavalcanti E;
    Infect Agent Cancer; 2022 Jul; 17(1):40. PubMed ID: 35902961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination.
    Lukaszuk K; Kiewisz J; Rozanska K; Dabrowska M; Podolak A; Jakiel G; Woclawek-Potocka I; Lukaszuk A; Rabalski L
    Vaccines (Basel); 2021 Jul; 9(8):. PubMed ID: 34451965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low BAU/ml values with 4 of 5 SARS CoV-2 spike-specific monoclonal antibodies in the Roche Elecsys antibody assay.
    Jassoy C; Biemann R; Hönemann M
    J Virol Methods; 2023 Nov; 321():114786. PubMed ID: 37516369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers.
    Saker K; Escuret V; Pitiot V; Massardier-Pilonchéry A; Paul S; Mokdad B; Langlois-Jacques C; Rabilloud M; Goncalves D; Fabien N; Guibert N; Fassier JB; Bal A; Trouillet-Assant S; Trabaud MA
    J Clin Microbiol; 2022 Jan; 60(1):e0174621. PubMed ID: 34705539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection.
    Migueres M; Chapuy-Regaud S; Miédougé M; Jamme T; Lougarre C; Da Silva I; Pucelle M; Staes L; Porcheron M; Diméglio C; Izopet J
    J Med Virol; 2023 Jan; 95(1):e28200. PubMed ID: 36207814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.